BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate
BioDlink congratulates Junshi …
BioDlink congratulates Junshi …
BEIJING, May 8, 2025 /PRNewswi…
Orders from Supermarkets and D…
HERLEV, Denmark, May 8, 2025 /…
Group Revenue Records Positive…
BEIJING, May 8, 2025 /PRNewswi…
SINGAPORE, May 8, 2025 /PRNews…
ZHENGZHOU, China, May 8, 2025 …